Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 4, 2026

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

Comparison of different LDL apheresis methods.

Ulrich Julius1, Antje Frind, Sergej Tselmin

  • 1University Hospital Dresden, Medical Clinic III, Fetscherstr. 74, 01307 Dresden, Germany. ulrich.julius@uniklinikum-dresden.de

Expert Review of Cardiovascular Therapy
|May 31, 2008
PubMed
Summary

Low-density lipoprotein (LDL) apheresis effectively reduces cardiovascular events and is indicated for high-risk patients. Further research is needed to compare different LDL apheresis methods for optimal clinical outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journal·2026
Same author

Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial.

European heart journal·2026
Same author

Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-up.

Atherosclerosis·2025
Same author

Correction: Asymmetric Dimethylarginine: A Never-Aging Story.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2025
Same author

Asymmetric Dimethylarginine: A Never-Aging Story.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2025
Same author

Neutrophil Extracellular Traps (NETs) as a Potential Target for Anti-Aging: Role of Therapeutic Apheresis.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2025

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • Lipid management is crucial for cardiovascular disease prevention.
  • Established guidelines recommend lower LDL cholesterol targets for high-risk individuals.

Purpose of the Study:

  • To outline the accepted indications for LDL apheresis.
  • To review the effects of various LDL apheresis methods on lipid profiles and inflammatory markers.
  • To highlight the need for comparative studies on LDL apheresis techniques.

Main Methods:

  • Review of current literature on LDL apheresis.
  • Analysis of acute reductions in LDL cholesterol, triglycerides, HDL-cholesterol, and lipoprotein(a).
  • Assessment of the impact of different methods on coagulation, C-reactive protein, and leukocytes.

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Experiment Videos

Last Updated: Jul 4, 2026

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Main Results:

  • LDL apheresis significantly reduces cardiovascular events.
  • While acute LDL cholesterol reductions vary, mean post-treatment values are similar across methods.
  • Serum triglycerides, HDL-cholesterol, and lipoprotein(a) are also acutely reduced.
  • Methods differ in their effects on coagulation, C-reactive protein, and leukocyte counts.

Conclusions:

  • LDL apheresis is a proven treatment for reducing cardiovascular events.
  • The evolving landscape of lipid management necessitates a broader application of LDL apheresis.
  • Prospective studies comparing LDL apheresis methods using hard clinical endpoints are urgently required.